New challenges in kidney cancer therapy: sunitinib

Ann Oncol. 2007 Jul:18 Suppl 9:ix83-6. doi: 10.1093/annonc/mdm298.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / pathology
  • Clinical Trials as Topic
  • Forecasting
  • Humans
  • Indoles / therapeutic use*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrroles / therapeutic use*
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Sunitinib
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Protein-Tyrosine Kinases
  • Receptors, Vascular Endothelial Growth Factor
  • Sunitinib